Sharps technology receives $30 million purchase order for prefillable copolymer syringes to be manufactured at sc facility

Signed po secures first 12 months of syringe product orders against sharps and nephron's five-year, $200 million syringe sales agreement.

STSS Ratings Summary

STSS Quant Ranking